BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 20/10/2017

FDA Announces Availability of Draft Guidances for Salmeterol Xinafoate and Fluticasone Propionate

The FDA has released draft guidances for the pharmaceutical industry on generic versions of three inhalation medications, including salmeterol xinafoate and fluticasone propionate, to provide recommendations on bioequivalence studies for abbreviated new drug applications.

Source: Federal Register — Food and Drug AdministrationOpen original release →